J. Keith Joung
 | This article needs additional citations for verification. |
J. Keith Joung is a Professor of Pathology at Harvard Medical School. He also serves as the Associate Chief of Pathology at Massachusetts General Hospital [1].
Education
Joung received his A.B. in the Biochemical Sciences from Harvard University in 1987, his M.D. from Harvard Medical School in 1996, and his Ph.D. from Harvard University in 1996. He completed his post-doctoral fellowship with Carl Pabo at the Massachusetts Institute of Technology and the Howard Hughes Medical Institute.
Career
Joung is well-regarded as a longstanding leader in the genome editing field and has contributed to the development of designer nucleases through protein engineering and detection of off-targets. He was the Founder of the Zinc Finger Consortium in the mid-2000's[2]. More recently, he worked on the development of the TAL effector nucleases and the RNA-guided CRISPR/Cas9 system.
He was the first to demonstrate the use of the CRISPR/Cas9 system in zebrafish and invented GUIDE-Seq to detect off-target effects in an unbiased manner.
References
